Latest Breaking News On - Antje bischof - Page 1 : comparemela.com

MS News That Caught My Eye: Cog Fog, Tolebrutinib, Ublituximab, Spinal Atrophy

MS News That Caught My Eye: Cog Fog, Tolebrutinib, Ublituximab, Spinal Atrophy
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Antje bischofLeigh charvetUniversity hospital munsterAmericas committee for treatmentYork universityResearch in multiple sclerosisNew yorkAmericas committeeMultiple sclerosisCord atrophy predicts silent progressionRelapse onset multiple sclerosis

#ACTRIMS2022 – Spinal Cord Atrophy in MS Predicts Silent Progression

#ACTRIMS2022 – Spinal Cord Atrophy in MS Predicts Silent Progression
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Antje bischofUniversity hospital munsterAmericas committee for treatmentResearch in multiple sclerosisAmericas committeeMultiple sclerosisCord atrophy predicts silent progressionRelapse onset multiple sclerosis

Spinal Cord Atrophy Predicts Silent Progression in MS

Spinal atrophy observed on MRI correlates with progression to secondary progressive MS when other signs may not be evident, new research shows.

United statesAnn arborWashington universitySan franciscoRosalyn rosenthalAntje bischofHanne crossBruceac creeBenjamin segalUniversity of californiaInstitute of translational neurologyDepartment of neurologyUcsf ms centerAmericas committee for treatmentUniversity hospitalUniversity of michigan multiple sclerosis center

Spinal cord atrophy significant predictor of silent progression in relapse-onset MS

WEST PALM BEACH, Fla. — Spinal cord atrophy appeared to predict silent progression in relapse-onset MS, according to results of a single-center observational study presented at ACTRIMS Forum.“Understanding progressive disease is an important challenge in MS,” Antje Bischof, MD, of the department of neurology and institute of translational neurology at the University Hospital

United statesUniversity hospitalWest palm beachAntje bischofJoe gramignaExpanded disability status scale